Original Article

Volume: 40 | Issue: 2 | Published: Jun 25, 2024 | Pages: 78 - 83 | DOI: 10.24911/BioMedica/5-1136

Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience


Authors: Natasha Bushra , Tahira Nasrin , Asifa Sarwar


Article Info

Authors

Natasha Bushra

Post graduate medical institute Lahore(PGMI), Pakistan.

Tahira Nasrin

Services Institute of Medical Sciences Lahore, Pakistan.

Asifa Sarwar

Services Institute of Medical Sciences Lahore, Pakistan.

Publication History

Received: January 25, 2024

Revised: March 29, 2024

Accepted: May 18, 2024

Published: June 25, 2024


Abstract


 

Background and Objective: Vitamin D deficiency emerges as a significant player in shaping reproductive health challenges including the ones with conception and fertility. The present study aims to ascertain the prevalence of vitamin D deficiency in the context of female infertility in the local population.

Methods: This cross-sectional study was conducted in the Obstetrics and Gynecology Department at Services Hospital Lahore, Pakistan, from May 30, 2021, to November 30, 2021. A total of 96 sub-fertile females, 20-40 years of age were recruited for the study after taking detailed history followed by clinical examination, and transvaginal ultrasound. The required information regarding body mass index (BMI), type of infertility, and socio-economic status were correlated with the laboratory assessment of serum vitamin D levels. Data were analyzed statistically using the chi-square test keeping p-value <0.05 as significant.

Results: The mean age of the patients was 29.43 ± 3.35 years, and the mean vitamin D level recorded was 19.03 ± 14.30 ng/ml. Notably, 97.9% of primary infertile females compared to 29.2% of secondary infertile patients exhibited vitamin D deficiency (p-value = 0.003). The deficient levels of Vitamin D were associated with the age, BMI, and socioeconomic status of these females.

Conclusion: Females with primary infertility have a notable Vitamin D deficiency compared to the ones with secondary infertility. Additional studies are pressingly needed to confirm a causal relationship and to investigate the potential therapeutic benefits of vitamin D supplementation.


Keywords: Females, infertility, Vitamin D, deficiency, body mass index.


Pubmed Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar. Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience. BioMedica. 2024; 25 (June 2024): 78-83. doi:10.24911/BioMedica/5-1136

Web Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar. Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience. https://biomedicapk.com/articles/1136 [Access: November 21, 2024]. doi:10.24911/BioMedica/5-1136

AMA (American Medical Association) Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar. Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience. BioMedica. 2024; 25 (June 2024): 78-83. doi:10.24911/BioMedica/5-1136

Vancouver/ICMJE Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar. Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience. BioMedica. (2024), [cited November 21, 2024]; 25 (June 2024): 78-83. doi:10.24911/BioMedica/5-1136

Harvard Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar (2024) Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience. BioMedica, 25 (June 2024): 78-83. doi:10.24911/BioMedica/5-1136

Chicago Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar. "Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience." 25 (2024), 78-83. doi:10.24911/BioMedica/5-1136

MLA (The Modern Language Association) Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar. "Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience." 25.June 2024 (2024), 78-83. Print. doi:10.24911/BioMedica/5-1136

APA (American Psychological Association) Style

Natasha Bushra, Tahira Nasrin, Asifa Sarwar (2024) Assessment of Vitamin D Levels in Infertile Females - A Tertiary Care Hospital Experience. , 25 (June 2024), 78-83. doi:10.24911/BioMedica/5-1136


Biomedica - Official Journal of University of Health Sciences, Lahore, Pakistan

Volume 40(2):78-83

ORIGINAL ARTICLE

Assessment of vitamin D levels in infertile females - a tertiary care hospital experience

Natasha Bushra1*, Tahira Nasrin2, Asifa Sarwar3

Received: 25 January 2024 Revised date: 29 March 2024 Accepted: 18 May 2024

Correspondence to: Natasha Bushra

*Assistant Professor, Department of Obstetrics and Gynecology, Post Graduate Medical Institute, Lahore, Pakistan.

Email: natashausman5@hotmail.com

Full list of author information is available at the end of the article.


ABSTRACT


Background and Objective:

Vitamin D deficiency emerges as a significant player in shaping reproductive health challenges including the ones with conception and fertility. The present study aims to ascertain the prevalence of vitamin D deficiency in the context of female infertility in the local population.


Methods:

This cross-sectional study was conducted in the Obstetrics and Gynecology Department at Services Hospital Lahore, Pakistan, from May 30, 2021, to November 30, 2021. A total of 96 sub-fertile females, 20-40 years of age were recruited for the study after taking detailed history followed by clinical examination, and transvaginal ultrasound. The required information regarding body mass index (BMI), type of infertility, and socio-economic status were correlated with the laboratory assessment of serum vitamin D levels. Data were analyzed statistically using the chi-square test keeping p-value <0.05 as significant.


Results:

The mean age of the patients was 29.43 ± 3.35 years, and the mean vitamin D level recorded was 19.03 ± 14.30 ng/ml. Notably, 97.9% of primary infertile females compared to 29.2% of secondary infertile patients exhibited vitamin D deficiency (p-value = 0.003). The deficient levels of Vitamin D were associated with the age, BMI, and socioeconomic status of these females.


Conclusion:

Females with primary infertility have a notable Vitamin D deficiency compared to the ones with secondary infertility. Additional studies are pressingly needed to confirm a causal relationship and to investigate the potential therapeutic benefits of vitamin D supplementation.


Keywords:

Females, infertility, Vitamin D, deficiency, body mass index.


Introduction

The impact of infertility is multifaceted, encompassing emotional, financial, and social dimensions. World Health Organization (WHO) defines infertility as the incapacity of a reproductive-age couple to achieve pregnancy within 12 months or more of unprotected sexual intercourse1. It can manifest as primary (no prior conception) or secondary (failure to conceive after a previous pregnancy without contraceptive use). Globally, around 10%-15% of couples experience infertility, with secondary infertility surpassing primary cases1,2. In Pakistan, the prevalence stands at 21.9%, with 3.9% attributed to primary infertility and 18% to secondary infertility3.

The repercussions of infertility extend beyond the physical realm, affecting psychological, economic, and social well-being, particularly for females. The challenges individuals and couples face underscore the need for comprehensive support systems and an understanding of the intricate ways infertility influences overall well-being4. Studies5,6 unveil that women undergoing infertility often face emotional harassment within marital homes, taking various forms such as verbal abuse, stigmatization, negative attitudes, physical abuse, and denial of basic needs and healthcare.

Calcium signaling, pivotal from fertilization through development, implantation, and organ differentiation, intersects with infertility. Vitamin D, a regulator of these signaling processes, plays a vital role. Infertility rates rise in the presence of vitamin D deficiency, emphasizing its importance in reproductive health7. Vitamin D maintains the stability of calcium and redox signaling pathways critical in the development of reproductive processes such as endometrial receptivity8. It influences reproductive functions in both genders, impacting in vitro fertilization (IVF) outcomes, features of polycystic ovarian syndrome (PCOS), and endometriosis in women9. Adequate vitamin D levels enhance embryo implantation rates and follicular development in IVF, and its deficiency is linked to the metabolic and endocrine features of PCOS and the inflammatory mechanisms in endometriosis. Vitamin D deficiency is more common in women with PCOS who are experiencing infertility compared to the general population. This deficiency is linked to various aspects of PCOS, including insulin resistance, hormonal imbalances, and metabolic issues, which can further complicate fertility problems10.

In the United States of America (USA), vitamin D deficiency is reported to affect 20%-48% of the adult population while in women with PCOS and infertility, the prevalence is significantly higher, ranging from 67%-85%11. In Pakistan, a cross-sectional survey was conducted with 27,880 individuals referred from the general out-patient-department (OPD) to dow diagnostic research and reference laboratory (DDRRL) units at Dow University of Health Sciences (DUHS) Karachi; the status of vitamin D indicates 31.2% insufficiency, 53.5% deficiency, and 15.3% within the normal range12. Additionally, vitamin D plays a role in sperm quality in men, affecting overall fertility. Therefore, the high prevalence of vitamin D deficiency in the population can lead to increased rates of infertility and complicated efforts to conceive13.

While numerous studies have reported an association between vitamin D deficiency and infertility, a notable gap still exists in our local population. The absence of empirical evidence regarding the extent of this issue in our local female population necessitated this study with an aim to determine the serum levels of Vitamin D in infertile female patients and find an association with their body mass index (BMI) and socioeconomic status.


Methods

This cross-sectional study was conducted in the Obstetrics and Gynecology Department, Unit II at Services Hospital Lahore, Pakistan, spanning from May 30, 2021, to November 30, 2021, following ethical approval from the institutional committee. A total of 96 women presenting in Gynae outdoors for the treatment of their infertility were included in the study. According to the standard guidelines, they were diagnosed to be sub-fertile according to their history of inability to conceive for the last 1 year with regular intercourse. Patients were categorized as primary or secondary infertile according to the WHO criteria1. The cause of infertility was ascertained after detailed history, clinical examination, and transvaginal ultrasound findings. Socioeconomic status was assigned as poor (income<50,000/month), middle (100-250,000/months), and upper (>300,000/month) to all recruited patients. All infertile women aged 20-40 years with who gave written informed consent were included in the study. Females if receiving pharmacological vitamin D or calcium supplementation before the date of 25 (OH)D concentration measurement, any history of malignancy, hypertension, diabetes, need for chronic medical treatments, autoimmune disorders, and any disorder that may impact on calcium or vitamin D metabolism, such as bone, parathyroid gland, kidney, and liver disorders were excluded. The sample size was calculated as n = 96 with a 95% confidence level, 9.5 % margin of error, and the expected percentage of Vit D deficiency in female infertility as 67%10. using www.raosoft.com. The sampling technique was non-probability purposive sampling. All patients underwent serum vitamin D level assessments from the quantitative detection of a total of 25 (OH)D levels using a commercially available kit based on a chemiluminescence technology. According to WHO recommendations, a 25 (OH)D value <20 ng/ml was considered deficient and a value ≥20 ng/ml was normal14. The required information regarding age, BMI, type of infertility, socio economic status, and vitamin D levels was collected on a predesigned proforma.


Statistical analysis

Data were analyzed by Statistical Package for Social Sciences (SPSS) version 23. Mean and standard deviations were calculated for quantitative variables, i.e., age, BMI, and vitamin D levels. Data were stratified for age, BMI, type of infertility, and socio-economic status. p values <0.05 were considered as statistically significant.


Results

The mean age of the patients was 29.43 ± 3.35 years. The mean BMI of the patients was 25.32 ± 2.48 kg/m2. According to this study, 43 (45.26%) patients were poor, 49 (51.58%) patients belonged to the middle class and 3 (3.16%) patients belonged to upper-income class. The mean vitamin D level of the patients was 19.03 ± 14.30 ng/ml with minimum and maximum levels of 1.20 and 86 ng/ml respectively as shown in Table 1. Vitamin D deficiency (defined as serum levels below 20 ng/ml)14 was observed in 61 out of 96 women, accounting for 63.54%.

The study population was evenly divided, with 48 women experiencing primary infertility and 48 women experiencing secondary infertility. Vitamin D deficiency was identified in 97.9% of primary infertile patients compared to 29.2% in secondary infertile patients, demonstrating statistical significance (p-value = 0.003).

The mean duration of primary infertility was 3.8 ± 2.1 years, with a range from 2 years to 5 years. The mean duration of secondary infertility was 4.5 ± 2.7 years, with a range from 3 years to 10 years. The most common reason for secondary infertility included PCOS, affecting 20 out of 48 women with secondary infertility. Tubal Factor Infertility was identified in 10 females, often due to previous pelvic inflammatory disease or endometriosis. Uterine factors including fibroids and adhesions were reported in 8 women while unexplained reason was a contributing factor in 6 females. Table 2 illustrates a noteworthy status of vitamin D deficiency among patients based on age groups. For those aged ≤ 30 years, 71.2% exhibited vitamin D deficiency, whereas among patients aged >30 years, the prevalence was 46.7% (p-value = 0.021). Similarly, in the context of BMI, patients with a BMI ≤ 25 kg/m2 had vitamin D deficiency in 79.1% of cases, contrasting with patients with a BMI >25 kg/m2, where the frequency was 50.9% (p-value = 0.004). Finally, the stratification between primary and secondary infertility revealed notable differences. Vitamin D deficiency was identified in 97.9% of primary infertile patients compared to 29.2% in secondary infertile patients (p-value = 0.003).

Table 1. Baseline characteristics of study population.

Characteristics
Total
N (%)
Mean SD Minimum Maximum
Maternal age
(years)
29.43 3.35 22.00 40.00
BMI 25.32 2.48 18.00 30.00
Vitamin D level (ng/ml) 19.03 14.30 1.20 86.00
Type of infertility
Primary infertility 17.5 ± 12.7 50.21 1.20 65
Secondary infertility 18.6 ± 12.8 67.36 2.5 84

Table 2. Comparison of vitamin D deficiency in multivariable analysis.

Variables Vitamin D deficiency Total p value
Yes No
Age (years) ≤30 47
71.2%
19
28.8%
66
100.0%
0.021
>30 14
46.7%
16
53.3%
30
100.0%
BMI (Kg/m2) ≤ 25 34
79.1%
9
20.9%
43
100.0%
0.004
>25 27
50.9%
26
49.1%
53
100.0%
Type of infertility Primary 47
97.9%
1
2.1%
48
100.0%
<0.001
Secondary 14
29.2%
34
70.8%
48
100.0%
Socioeconomic status Poor 34
79.1%
9
20.9%
43
100.0%
0.003
Middle 25
51.0%
24
49.0%
49
100.0%
Upper 1
33.3%
2
66.7%
3
100.0%

Discussion

Vitamin D treatment has demonstrated its efficacy by influencing cellular processes, such as the downregulation of follicle-stimulating hormone receptors and the role of receptors controlling antimullerian genes15. This is associated with a rise in the production of progesterone and 3β-hydroxysteroid dehydrogenase. This intervention showcases favorable effects on metabolic dysregulations in PCOS marked by a profound effect on androgen levels, potentially fostering a healthier ovarian physiology16. The prevalence of vitamin D deficiency and its effect on overall global health is a matter of concern, affecting an estimated 1 billion people worldwide17. Within the scope of this study focusing on infertility in females, vitamin D deficiency was identified in 63.54% of patients.In order to look at the relationship of pregnancy rate with vitamin D levels, Rudick et al.18 conducted a retrospective cohort research involving 18 infertile women undergoing IVF. Remarkably, the investigators discovered a correlation between declining vitamin D levels and a linear fall in pregnancy rate.

Examining related studies, Mogili et al.19 conducted research involving 256 infertile women with PCOS. Their findings revealed a deficiency of vitamin D, observed in 70.3% of the participants, with 20.3% categorized as having insufficiency of vitamin D and only 9.4% of them having normal vitamin D levels. Additionally, 31.25% of the women exhibited signs of metabolic syndrome.

The median serum 25-hydroxyvitamin D concentration undergoes a reduction in the primary trimester of the calendar year, culminating in a subsequent increase in the prevalence of deficiency thus underscoring a significant impact of seasonality on vitamin D status20. It is noteworthy that this deficiency has been linked to various gynecological issues. Within the cohort of women experiencing infertility, the documented frequency of Vitamin D deficiency spans from 20% to 66.8%, manifesting variances across diverse nations21. In women with PCOS experiencing infertility, the prevalence, however, is notably higher, ranging from 67% to 85%22. Basile et al.23 in their study, arrived at the conclusion that Vitamin D deficiency is widespread, impacting both fertile and infertile women. This deficiency is linked to various adverse outcomes in conditions associated with infertility. Authors, in their systematic review, revealed the presence of vitamin D receptors and metabolizing enzymes in the reproductive tissues of both males and females. They posited that vitamin D could potentially exert an influence on the synthesis of sex hormones, specifically estradiol and progesterone, in women of good health, with heightened concentrations of 25-hydroxyvitamin D potentially being linked to the presence of endometriosis24.

Serum 25 (OH)D levels are highly deficient in women seeking medical help for couple’s infertility. Dhamayanti et al.25 in their study, concluded that there is a high prevalence of hypovitaminosis D among women of childbearing age. Evidence from observational studies indicates an important role of vitamin D in IVF success, which is probably mediated through vitamin D effects on endometrium26. Research findings indicate seasonal fluctuations in circulating 25 (OH)D levels among a homogeneous cohort of women seeking medical assistance for couple’s infertility in northern Italy. Ott et al27. demonstrated in a prospective cohort study that BMI and 25 (OH)D deficiency served as significant predictive parameters in 91 anovulatory infertile women with PCOS in 2012. They noted that 25 (OH)D levels below 10 ng/ml reduced the likelihood of follicle development by 67% and the probability of becoming pregnant by 76%.

Our finding is also similar to the study conducted that also concluded major implications of vitamin D deficiency both for infertile patients and in patients undergoing IVF28. We noticed that both groups including primary and secondary infertility exhibited significant deficiencies, but those with secondary infertility had marginally higher levels, possibly due to residual effects from prior pregnancies and lactation.

Although infertility among women is a multifactorial condition and might be attributed to various causes, in 50% of cases, the clear etiology is unknown. However, among conditions of infertility in which the etiology results are not clear, an increased frequency of abnormalities in the immune system has been reported29. We described that having vitamin D deficiency is associated with females diagnosed with primary infertility. Our results are mainly in line with a Brazilian study30 in which low vitamin D levels were independent risk factors for primary infertility in women but a recent meta-analysis on the role of vitamin D on reproductive outcome concluded that a well-designed randomized controlled trial with a large sample size are required to evaluate the effect of vitamin D supplementation on female fertility.


Conclusion

Vitamin D deficiency in the local population is associated with female infertility, particularly in cases with primary infertility, and exhibits a significant relationship with the age and BMI of these infertile females. Therefore, Vitamin D could serve as a promising therapeutic option if thoroughly investigated within the infertile female population.


Limitations of the study

Due to limited existing literature on this subject, it is recommended that future research trials should explore this topic with larger sample sizes and the role of therapeutic vitamin D deficiency. One limitation of our study is that we did not explore the association of each cause of secondary infertility with vitamin D deficiency. Additionally, emphasizing community-based studies over hospital-based studies is suggested for a more comprehensive understanding of the implications.


Acknowledgement

The authors would like to extend their sincere appreciation to the dedicated staff of the Pathology Department of Services Hospital Lahore, Pakistan, for their assistance in the assessment of vitamin D levels.


List of Abbreviations

WHO World Health Organization
BMI Body mass index
IVF In vitro fertilization
PCOS Polycystic ovarian syndrome

Conflict of interest

None to declare.


Grant support and financial disclosure

None to disclose.


Ethics approval

The study was approved by the Institutional Review Committee of Services Institute of Medical Sciences, Lahore, Pakistan, vide Letter No. IRB/2021/880/SIMS dated 5th October 2021.


Authors’ contributions

NB: Concept and design of study, acquisition, and analysis of data, drafting of manuscript, reviewing it critically for important intellectual content.

TN: Concept and design of study, acquisition, and analysis of data, drafting of manuscript.

AS: Acquisition and analysis of data, drafting of manuscript

ALL AUTHORS: Approval of the final version of the manuscript to be published.


Authors’ Details

Natasha Bushra1, Tahira Nasrin2, Asifa Sarwar3

  1. Assistant Professor, Department of Obstetrics and Gynecology, Post Graduate Medical Institute, Lahore, Pakistan
  2. Senior Registrar, Department of Obstetrics and Gynecology, Services Hospital, Lahore, Pakistan
  3. Postgraduate Resident, Department of Obstetrics and Gynecology, Services Hospital, Lahore, Pakistan

References

  1. World Health Organization. Infertility. Geneva, Switzerland: WHO [cited 2024 May 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/infertility#:~:text=Infertility%20is%20a%20disease%20of,causes%20of%20infertility%20are%20preventable
  2. Yousaf I, Shamshad R, Tariq M. Analysis of role of vitamin D deficiency in female infertility. Indo Am J Pharm Sci. 2018;5(8):7722–8. http://doi.org/10.5281/zenodo.1344162
  3. Simpson S, Pal L. Vitamin D and infertility. Curr Opin Obstet Gynecol. 2023;35(2):88–93. https://doi.org/10.1097/GCO.0000000000000887
  4. Berry S, Seidler K, Neil J. Vitamin D deficiency and female infertility: a mechanism review examining the role of vitamin D in ovulatory dysfunction as a symptom of polycystic ovary syndrome. J Reprod Immunol. 2022;146:103633. https://doi.org/10.1016/j.jri.2022.103633
  5. Sharma S, Sharma R, Manani P, Prasad IV. Infertility among married women in Northern India: a qualitative study of coping strategies and social stigmas. Int J Womens Health Reprod Sci. 2024;12(1):45–53. https://doi.org/10.15296/ijwhr.2023.7890
  6. Hassan SUN, Zahra A, Parveen N, Iqbal N, Mumtaz S, Batool A. Quality of infertility care services and emotional health of South Asian women. Psychol Res Behav Manag. 2022;15:1103–14. https://doi.org/10.2147/PRBM.S357301
  7. Jensen A, Nielson ML, Guleria S, Kjaer SK, Heitmann BL, Kesmodel US. Chances of live birth after exposure to vitamin D-fortified margarine in women with fertility problems: results from a Danish population-based cohort study. Fertil Steril. 2020;113(2):383–91. https://doi.org/10.1016/j.fertnstert.2019.09.017
  8. Reddy AM, Iqbal M, Chopra H, Urmi S, Junapudi S, Bibi S, et al. Pivotal role of vitamin D in mitochondrial health, cardiac function, and human reproduction. EXCLI J. 2022;21:967–90. https://doi.org/10.17179/excli2022-4935
  9. Zhou X, Wu X, Luo X, Shao J, Guo D, Deng B. Effect of vitamin D supplementation on in vitro fertilization outcomes: a trial sequential meta-analysis of 5 randomized controlled trials. Front Endocrinol. 2022;13:852428. https://doi.org/10.3389/fendo.2022.852428
  10. Neysanian GH, Taebi M, Rezaeian A, Nasr-Esfahani MH, Jahangirifar M. The effects of serum and follicular fluid vitamin D levels on assisted reproductive techniques: a prospective cohort study. Int J Fertil Steril. 2021;15(4):280–285. https://doi.org/10.22074/IJFS.2021.138605.1033
  11. Moridi I, Chen A, Tal O, Tal R. The association between vitamin D and anti-Mullerian hormone: a systematic review and meta-analysis. Nutrients. 2020;12(5):1567. https://doi.org/10.3390/nu12061567
  12. Arshad S, Zaidi SJA. Vitamin D levels among children, adolescents, adults, and elders in Pakistani population: a cross-sectional study. BMC Public Health. 2022;22(1):2040. https://doi.org/10.1186/s12889-022-14526-6
  13. Aramesh S, Alifarja T, Jannesar R, Ghaffari P, Vanda R, Bazarganipour F, et al. Does vitamin D supplementation improve ovarian reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-and-after interventional study. BMC Endocr Disord. 2021;21:126. https://doi.org/10.1186/s12902-021-00786-7
  14. Paffoni A, Ferrari S, Viganò P, Pagliardini L, Papaleo E, Candiani M, et al. Vitamin D deficiency and infertility: insights from in vitro fertilization cycles. J Clin Endocrinol Metab. 2014;99(11):E2372–6. https://doi.org/10.1210/jc.2014-1802
  15. Lerchbaum E, Theiler-Schwetz V, Kollmann M, Wölfler M, Pilz S, Obermayer-Pietsch B, et al. Effects of vitamin D supplementation on surrogate markers of fertility in PCOS women: a randomized controlled trial. Nutrients. 2021;13(2):547. https://doi.org/10.3390/nu13020547
  16. Lerchbaum E, Rabe T. Vitamin D and female fertility. Curr Opin Obstet Gynecol. 2014;26(3):145–50. https://doi.org/10.1097/GCO.0000000000000065
  17. Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of vitamin D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. 2016;9(2):329–38. https://doi.org/10.1586/17512433.2016.1122519
  18. Rudick B, Ingles S, Chung K, Stanczyk F, Paulson R, Bendikson K, et al. Characterizing the influence of vitamin D levels on IVF outcomes. Hum Reprod. 2012 Nov;27(11):3321–7. https://doi.org/10.1093/humrep/des280
  19. Mogili KD, Karuppusami R, Thomas S, Chandy A, Kamath MS, Tk A, et al. Prevalence of vitamin D deficiency in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome - a prospective observational study. Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:15–9. https://doi.org/10.1016/j.ejogrb.2018.08.001
  20. Vandevijvere S, Amsalkhir S, Van Oyen H, Moreno-Reyes R. High prevalence of vitamin D deficiency in pregnant women: a national cross-sectional survey. PLoS One. 2012;7(8):e43868. https://doi.org/10.1371/journal.pone.0040575
  21. Pagliardini L, Viganò P, Molgora M, Persico P, Salonia A, Vailati SH, et al. High prevalence of vitamin D deficiency in infertile women referring for assisted reproduction. Nutrients. 2015;7(12):9972–84. https://doi.org/10.3390/nu7125516
  22. Krul-Poel Y, Snackey C, Louwers Y, Appelman-Dijkstra NM, Lambalk CB, Laven JSE, et al. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome (PCOS): a systematic review. Eur J Endocrinol. 2013;169:853–65. https://doi.org/10.1530/EJE-13-0617
  23. Basile S, Salvati L, Artini PG, Casarosa E, Grimaldi E, Volpe A. Vitamin D and infertility: a narrative review. Gynecol Endocrinol Reprod Med. 2021; 2(1):15–20. https://doi.org/10.53260/GREM.212013
  24. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012;166(5):765–78. https://doi.org/10.1530/EJE-11-0984
  25. Dhamayanti M, Iskandar K, Hidayati SN, Lertbunnaphong T, Wiradnyani LA, Yuniarti V, et al. Association of maternal vitamin D deficiency and infants’ neurodevelopmental status: a cohort study on vitamin D and its impact during pregnancy and childhood in Indonesia. J Paediatr Child Health. 2020;56(1):16–21. https://doi.org/10.1111/jpc.14481
  26. Triggianese P, Watad A, Cedola F, De Carolis C, Perricone C, Aloe G, et al. Vitamin D deficiency in an Italian cohort of infertile women. Am J Reprod Immunol. 2017;78(4):1–5. https://doi.org/10.1111/aji.12733
  27. Ott J, Wattar L, Kurz C, Seemann R, Huber J, Mayerhofer K, et al. Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study. Eur J Endocrinol. 2012;166(5):897. https://doi.org/10.1530/EJE-11-1070
  28. Doryanizadeh L, Morshed-Behbahani B, Parsanezhad ME, Fallahzadeh H, Akhondi MM, Talebi M, et al. Calcitriol effect on outcomes of in vitro fertilization in infertile women with vitamin D deficiency: a double-blind randomized clinical trial. Z Geburtshilfe Neonatol. 2021;225(3):226–31. https://doi.org/10.1055/a-1206-1064
  29. Reyman M, Verrijn Stuart A, van Summeren M, Dijck-Brouwer DA, Muskiet FA, Conchillo JM, et al. Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity. Int J Obes. 2014;38(1):46–52. https://doi.org/10.1038/ijo.2013.75
  30. Lopes VM, Lopes JRC, Brasileiro JPB, de Oliveira I, Lacerda RP, Andrade MRD, et al. High prevalence of vitamin D deficiency among Brazilian women of reproductive age. Arch Endocrinol Metab. 2017;6(1):21-7. https://doi.org/10.1590/2359-3997000000216